Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Salt Lake City, April 07, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in ...

How much does a household have to make to be considered upper middle class? The answer varies widely depending on where you live, according to a recent study conducted by personal finance site ...

[Maximilian Milovidov is a freshman at Columbia University and a member of TikTok's Youth Council. He used a large language model to edit this essay for length and a human to edit for content. This ...

There are 13 Mewgenics classes in this cat breeding turn-based roguelike, although you'll only start the game with four. Knowing how each of the classes works, alongside what the best ones are and how ...

Air India’s A350 Business Class has surprising first-class upgrades, gourmet meals, engaged flight attendants, and a fully equipped suite for long-haul flights. The unexpected luxury of Air India’s ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. In 2025, more than 1,700 class lawsuits were settled for a total of $79 billion—nearly ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...